Midazolam Injection, Solution
Product Images NDC 63323-411

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Midazolam (NDC 63323-411). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Fk Logo)

FDA Label Image

Figure 1 (Midazolam Figure1)

A line graph titled 'pH Dependence of Open-ring Form in Water' displaying the percentage of open-ring form plotted on the vertical axis and pH values from 2.5 to 5.5 on the horizontal axis. The graph shows a steep decrease in the open-ring form percentage as pH increases.*

FDA Label Image

Structure (Midazolam Str 1)

Chemical structure of Midazolam Hydrochloride, the active ingredient in the Midazolam injection solution by Fresenius Kabi USA. The diagram shows the molecular structure including chlorine (Cl) and fluorine (F) atoms, representing the hydrochloride salt form.*

FDA Label Image

Structure 2 (Midazolam Str2)

Chemical structure diagram showing the conversion between Midazolam and its open-ring form. The illustration depicts the molecular structures of both forms, highlighting the chemical change from the ring structure of Midazolam to its open-ring form.*

FDA Label Image

Midazolam Tray 02

Midazolam Injection, USP label for 10 mg per 2 mL (5 mg per mL) solution containing benzyl alcohol, intended for intramuscular or intravenous use. The label states it is sterile, includes storage instructions, and lists the labeler as Fresenius Kabi USA, LLC. The NDC is 63323-412.*

FDA Label Image

Midazolam Tray 10

Midazolam Injection, USP 10 mg per 10 mL (1 mg per mL) solution for intramuscular or intravenous use. Each mL contains 1 mg midazolam hydrochloride compounded with 0.8% sodium chloride and preservatives. The package contains ten 10 mL vials. Labeler is Fresenius Kabi USA, LLC. NDC 63323-411-10.*

FDA Label Image

Midazolam Tray 12

Midazolam Injection, USP 2 mg per 2 mL (1 mg per mL) solution for injection, labeled for intramuscular or intravenous use. Contains benzyl alcohol as a preservative. Packaged in 25 x 2 mL vials. Labeler is Fresenius Kabi USA, LLC. Includes storage instructions and regulatory information on the label.*

FDA Label Image

Midazolam Tray 125

Midazolam Injection, USP 5 mg per 5 mL (1 mg per mL) solution for intramuscular or intravenous use, supplied in 25 vials of 5 mL each. Label indicates presence of benzyl alcohol as preservative and includes storage instructions (20-25°C). The product is labeled by Fresenius Kabi USA, LLC with NDC 63323-411-25.*

FDA Label Image

Midazolam Tray 25

Midazolam Injection, USP 5 mg per 1 mL (5 mg per mL) solution in a carton label. The label specifies use for intramuscular or intravenous administration, contains Benzyl Alcohol, and is for prescription use only. Packaged as 25 x 1 mL vials, labeled by Fresenius Kabi USA, LLC. Includes dosage and storage information, website, and barcode.*

FDA Label Image

Midazolam Vial 03

Midazolam Injection, USP 10 mg per 2 mL (5 mg per mL) vial for intramuscular or intravenous use. The label states the vial contains 2 mL and includes Benzyl Alcohol. The product is labeled by Fresenius Kabi USA, LLC and includes a barcode and lot/expiration information area.*

FDA Label Image

Midazolam Vial 113

Midazolam 1 mg/mL Injection, USP solution in a 10 mL vial by Fresenius Kabi USA, LLC. The label indicates 10 mg per 10 mL (1 mg/mL) strength, sterile formulation for intramuscular or intravenous use. It contains benzyl alcohol as a preservative, with storage instructions between 20° to 25°C (68° to 77°F). The label includes NDC 63323-411-13 and lot/expiration placeholders.*

FDA Label Image

Midazolam Vial 118

Midazolam Injection USP, 1 mg/mL (5 mg per 5 mL) solution in a 5 mL vial. The label states it is sterile and for intramuscular or intravenous use only. Contains benzyl alcohol. The product is by Fresenius Kabi USA, LLC, with NDC 63323-411-18.*

FDA Label Image

Midazolam Vial 13

Midazolam Injection, USP 5 mg per mL solution in a 10 mL vial by Fresenius Kabi USA, LLC. The label states it is for intramuscular or intravenous use, contains benzyl alcohol, and includes storage instructions to keep at 20 to 25°C (68 to 77°F). The product is sterile and contains 1 mg of midazolam hydrochloride per mL.*

FDA Label Image

Midazolam Vial 15

Label for Midazolam Injection, USP 2 mg per 2 mL (1 mg per mL) solution. It indicates use for intramuscular or intravenous administration and contains benzyl alcohol. The vial size is 2 mL. Labeler is Fresenius Kabi USA, LLC. The label includes a barcode and lot/expiration information area.*

FDA Label Image

Midazolam Vial 18

Midazolam Injection, USP 5 mg per 1 mL (5 mg/mL) vial label. The label states it is for intramuscular or intravenous use only and contains benzyl alcohol. The label also includes the strength, route, and cautions, along with a barcode and lot/expiration date area. The labeler is Fresenius Kabi USA, LLC.*

FDA Label Image

Midtray 42645f

Midazolam Injection, USP 5 mg per mL (50 mg per 10 mL) solution for injection vial label. For intramuscular or intravenous use only. Contains benzyl alcohol as preservative. Sterile solution provided in 10 mL vial. Manufactured by Fresenius Kabi USA, LLC. Includes storage instructions and a barcode.*

FDA Label Image

Class (Schedule Classiv)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.